INT308557

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.66
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 1.12
Pain Relevance 0.40

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endosome (VPS45) vesicle-mediated transport (VPS45) Golgi apparatus (VPS45)
intracellular (VPS45) molecular_function (VPS45) cellular_component (VPS45)
VPS45 (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 6 100.00 Very High Very High Very High
Calcium channel 4 100.00 Very High Very High Very High
beta blocker 2 100.00 Very High Very High Very High
Pain 6 5.00 Very Low Very Low Very Low
cva 6 5.00 Very Low Very Low Very Low
cINOD 4 5.00 Very Low Very Low Very Low
COX2 2 5.00 Very Low Very Low Very Low
iatrogenic 2 5.00 Very Low Very Low Very Low
alcohol 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hypertension 136 100.00 Very High Very High Very High
Cancer 56 75.28 Quite High
Cardiovascular Disease 16 5.00 Very Low Very Low Very Low
Renal Cancer 6 5.00 Very Low Very Low Very Low
Pain 6 5.00 Very Low Very Low Very Low
Myocardial Infarction 6 5.00 Very Low Very Low Very Low
Heart Rate Under Development 4 5.00 Very Low Very Low Very Low
Death 4 5.00 Very Low Very Low Very Low
Chronic Renal Failure 4 5.00 Very Low Very Low Very Low
Stress 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Panel members have routinely used many classes of agents to treat VSP inhibitor–induced hypertension, including thiazide diuretics, beta blockers, dihydropyridine and non-dihydropyridine calcium channel antagonists, angiotensin-converting enzyme inhibitors, and angiotensin receptor antagonists.
Gene_expression (inhibitors) of VSP inhibitor associated with beta blocker, antagonist, calcium channel and hypertension
1) Confidence 0.66 Published 2010 Journal JNCI Journal of the National Cancer Institute Section Body Doc Link PMC2864290 Disease Relevance 0.56 Pain Relevance 0.20
Panel members have routinely used many classes of agents to treat VSP inhibitor–induced hypertension, including thiazide diuretics, beta blockers, dihydropyridine and non-dihydropyridine calcium channel antagonists, angiotensin-converting enzyme inhibitors, and angiotensin receptor antagonists.
Gene_expression (antagonists) of VSP inhibitor associated with beta blocker, antagonist, calcium channel and hypertension
2) Confidence 0.66 Published 2010 Journal JNCI Journal of the National Cancer Institute Section Body Doc Link PMC2864290 Disease Relevance 0.56 Pain Relevance 0.20

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox